Clinical trials: None (i.e. Healthy Volunteers)

None (i.e. Healthy Volunteers)

Levomilnacipran in Healthy Males

• Unknown status
• Age: 18 to 40 years
• Phase 4

Levomilnacipran is an antidepressant currently approved in Canada to treat Major Depressive Disorder (MDD). Thirty-six healthy male participants will receive escalating doses of levomilnacipran, duloxetine, or placebo every 7…

Trial name

NCT03249311

Testing

Levomilnacipran, Duloxetine

Where

Canada

Volunteers

36 people, healthy volunteers welcome

Sponsor

University of Ottawa